In a 50‑year‑old woman taking medroxyprogesterone acetate 10 mg daily for five days, how many days after the last dose should the menstrual bleeding stop?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Medroxyprogesterone Acetate 10mg: Expected Timing for Bleeding Cessation

When taking medroxyprogesterone acetate 10mg daily for 5 days, withdrawal bleeding typically begins 2-7 days after the last dose and should stop within 3-7 days of onset, meaning complete cessation usually occurs within 7-14 days total from the last pill.

Understanding the Mechanism and Timeline

Medroxyprogesterone acetate (MPA) transforms proliferative endometrium into secretory endometrium 1. When you stop the medication after 5 days, the sudden withdrawal of progestogen triggers endometrial shedding—this is withdrawal bleeding, not a natural period.

Expected Bleeding Pattern:

Onset of bleeding:

  • Withdrawal bleeding typically starts 2-7 days after the last dose 2
  • The timing depends on endometrial thickness and endogenous estrogen levels

Duration of bleeding:

  • Once bleeding starts, it should cease within 3-7 days in most women
  • Studies show median time to bleeding cessation is approximately 3 days from onset 3

Important Clinical Context for a 50-Year-Old Woman

At age 50, this patient is likely perimenopausal or early menopausal, which creates important considerations:

Key Factors Affecting Response:

  1. Endogenous estrogen levels: Lower estrogen in perimenopause may result in:

    • Lighter withdrawal bleeding
    • Shorter duration of bleeding
    • Possibly no bleeding at all if endometrium is atrophic
  2. Endometrial thickness matters: Studies demonstrate that endometrial thickness significantly correlates with bleeding response 2. Thinner endometrium (common at age 50) may produce minimal or no withdrawal bleeding.

  3. This is NOT treatment for active bleeding: The FDA label specifically states MPA is "not recommended in secondary amenorrhea or dysfunctional uterine bleeding" when given parenterally, and oral therapy protocols differ 1. Your 5-day regimen appears to be a progestogen challenge test rather than treatment for active bleeding.

What to Tell Your Patient

Expected timeline:

  • Bleeding should start within 2-7 days after the last pill
  • Once started, bleeding should stop within 3-7 days
  • Total time from last dose to complete cessation: 7-14 days maximum

When to Be Concerned:

Contact provider if:

  • Heavy bleeding (soaking through a pad per hour for 2+ hours)
  • Bleeding continues beyond 14 days from the last dose
  • Severe pain or fever develops
  • No bleeding occurs AND pregnancy is possible

Clinical Pitfalls to Avoid

  1. Don't confuse this with treatment protocols: For acute abnormal uterine bleeding, MPA is given at 20mg three times daily initially, then tapered 3. Your 10mg daily × 5 days is a much lower dose, typically used as a progestogen withdrawal test.

  2. Age-related considerations: At 50, "masking of climacteric" is relevant 1. If she doesn't bleed, this may indicate low estrogen/menopausal status rather than treatment failure.

  3. No bleeding doesn't always mean failure: In perimenopausal women with atrophic endometrium, absence of withdrawal bleeding after MPA is common and doesn't necessarily indicate pathology—it may simply reflect insufficient endometrial proliferation due to low estrogen.

  4. This is NOT contraception: While DMPA (depot form) is contraceptive, your 5-day oral regimen provides no contraceptive protection 1.

Bottom Line

For your 50-year-old patient: expect withdrawal bleeding to start within 2-7 days after the last 10mg MPA dose, with bleeding stopping 3-7 days after it begins—total cessation within 7-14 days from the last pill. If bleeding hasn't stopped by day 14 post-treatment or is excessively heavy, clinical evaluation is warranted to rule out structural pathology (fibroids, polyps) or other underlying conditions 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.